KNOWLEDGE / Publication / POST
November 8, 2021

The baseline pain variability (BPV) has often been presented as positively correlating with the placebo response (PR) and associated with a lack of consistency in the subjects’ pain evaluation. Excluding high BPV subjects should then improve the precision of the treatment response. Another common method to increase the essay sensitivity is to adjust the analysis for covariates associated with the response. We aimed here at optimizing this essay sensitivity while combining both the exclusion of high BPV subjects with adjusted analysis.


We used the data from a randomized, placebo-controlled study with 171 osteoarthritis subjects. Up to 25% of the subjects with the highest BPV were excluded. In parallel, an adjustment for the Placebell placebo covariate was tested and the improvement in assay sensitivity was estimated.


The subjects’ exclusion didn’t significantly change the endpoints variance in the study, despite significant correlations between BPV and endpoints. On a positive note, this exclusion didn’t attenuate the performance of the adjustment which improve the essay sensitivity by up-to 37%.


The high BPV subjects exclusion can be used in combination with covariate adjustment to improve the essay sensitivity. Surprisingly, however, this exclusion didn’t seem to have a strong impact on the endpoints’ variance in the study. Overall, the adjustment seemed to bring larger gains in precision and power than the high BPV subjects exclusion. 

Scientific Poster
Arthur Ooghe, Samuel Branders, Alvaro Pereira
November 8, 2021
CNS Summit


Related content


Correcting For The Individual Patient Regression To The Mean Effect

Often, the primary endpoint of RCTs is defined as a change from baseline of a continuous outcome. In…

Type: Scientific Poster
Authors: Samuel Branders, PhD; Guillaume Bernard, PhD; Alvaro Pereira, PhD
Conference: American Society for Clinical Pharmacology and Therapeutics
Read More

Do Environmental Parameters Influence The Prediction Of The Placebo Response?

This proof-of-concept study on peripheral neuropathic pain patients investigates the potential influence of the investigator on the placebo…

Read More

Bayesian Modeling Of The Placebo Response In Neuropathic Pain

In analgesia randomized clinical trials (RCTs), the magnitude and the variability of the placebo response have a negative…

Type: Scientific Poster
Authors: Samuel Branders, PhD; Alvaro Pereira, PhD; Frederic Clermont, PhD; Chantal Gossuin; Dominique Demolle, PhD
Conference: Promoting Statistical Insight Conference
Read More

The next frontier in clinical research & patient management

We’re proud to be leading the charge into the next era of drug development.
Cognivia helps clinical trials reduce data variability, empower decision-making, and accelerate the launch of new therapies.
Tell us about your clinical trial below and we’ll be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.